Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: INNOVATIVE VACCINE TECHNOLOGIES
Firm Income Reported for This Client
$810K
Not substituted for client expenses
Summary
INNOVATIVE VACCINE TECHNOLOGIES is an organization, based in UT. Its political footprint includes $810K in lobbying-firm income reported for this client. Lobbying activity focuses on Medical/Disease Research/Clinical Labs, Budget/Appropriations. Political activity spans from 2021 to 2026.